These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


172 related items for PubMed ID: 27105818

  • 1. NEU3 inhibitory effect of naringin suppresses cancer cell growth by attenuation of EGFR signaling through GM3 ganglioside accumulation.
    Yoshinaga A, Kajiya N, Oishi K, Kamada Y, Ikeda A, Chigwechokha PK, Kibe T, Kishida M, Kishida S, Komatsu M, Shiozaki K.
    Eur J Pharmacol; 2016 Jul 05; 782():21-9. PubMed ID: 27105818
    [Abstract] [Full Text] [Related]

  • 2. Silencing of membrane-associated sialidase Neu3 diminishes apoptosis resistance and triggers megakaryocytic differentiation of chronic myeloid leukemic cells K562 through the increase of ganglioside GM3.
    Tringali C, Lupo B, Cirillo F, Papini N, Anastasia L, Lamorte G, Colombi P, Bresciani R, Monti E, Tettamanti G, Venerando B.
    Cell Death Differ; 2009 Jan 05; 16(1):164-74. PubMed ID: 18820643
    [Abstract] [Full Text] [Related]

  • 3. NEU3 activity enhances EGFR activation without affecting EGFR expression and acts on its sialylation levels.
    Mozzi A, Forcella M, Riva A, Difrancesco C, Molinari F, Martin V, Papini N, Bernasconi B, Nonnis S, Tedeschi G, Mazzucchelli L, Monti E, Fusi P, Frattini M.
    Glycobiology; 2015 Aug 05; 25(8):855-68. PubMed ID: 25922362
    [Abstract] [Full Text] [Related]

  • 4. Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway.
    Li Y, Huang X, Zhang J, Li Y, Ma K.
    Int J Biochem Cell Biol; 2013 Nov 05; 45(11):2349-58. PubMed ID: 23968914
    [Abstract] [Full Text] [Related]

  • 5. Ganglioside GM3 promotes carcinoma cell proliferation via urokinase plasminogen activator-induced extracellular signal-regulated kinase-independent p70S6 kinase signaling.
    Wang XQ, Sun P, Go L, Koti V, Fliman M, Paller AS.
    J Invest Dermatol; 2006 Dec 05; 126(12):2687-96. PubMed ID: 16826166
    [Abstract] [Full Text] [Related]

  • 6. Membrane type sialidase inhibits the megakaryocytic differentiation of human leukemia K562 cells.
    Jin UH, Ha KT, Kim KW, Chang YC, Lee YC, Ko JH, Kim CH.
    Biochim Biophys Acta; 2008 May 05; 1780(5):757-63. PubMed ID: 18339327
    [Abstract] [Full Text] [Related]

  • 7. Enhanced expression of membrane-associated sialidase Neu3 decreases GD3 and increases GM3 on the surface of Jurkat cells during etoposide-induced apoptosis.
    Azuma Y, Sato H, Higai K, Matsumoto K.
    Biol Pharm Bull; 2007 Sep 05; 30(9):1680-4. PubMed ID: 17827720
    [Abstract] [Full Text] [Related]

  • 8. A crucial role of plasma membrane-associated sialidase in the survival of human cancer cells.
    Wada T, Hata K, Yamaguchi K, Shiozaki K, Koseki K, Moriya S, Miyagi T.
    Oncogene; 2007 Apr 12; 26(17):2483-90. PubMed ID: 17334392
    [Abstract] [Full Text] [Related]

  • 9. Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside.
    Wang XQ, Yan Q, Sun P, Liu JW, Go L, McDaniel SM, Paller AS.
    Cancer Res; 2007 Oct 15; 67(20):9986-95. PubMed ID: 17942932
    [Abstract] [Full Text] [Related]

  • 10. Ganglioside GM3 induces cumulus cell apoptosis through inhibition of epidermal growth factor receptor-mediated PI3K/AKT signaling pathways during in vitro maturation of pig oocytes.
    Park HJ, Chae SK, Kim JW, Yang SG, Jung JM, Kim MJ, Wee G, Lee DS, Kim SU, Koo DB.
    Mol Reprod Dev; 2017 Aug 15; 84(8):702-711. PubMed ID: 28585705
    [Abstract] [Full Text] [Related]

  • 11. Ganglioside GM3 inhibits hepatoma cell motility via down-regulating activity of EGFR and PI3K/AKT signaling pathway.
    Huang X, Li Y, Zhang J, Xu Y, Tian Y, Ma K.
    J Cell Biochem; 2013 Jul 15; 114(7):1616-24. PubMed ID: 23355442
    [Abstract] [Full Text] [Related]

  • 12. Potentiation of epidermal growth factor-mediated oncogenic transformation by sialidase NEU3 leading to Src activation.
    Yamamoto K, Takahashi K, Shiozaki K, Yamaguchi K, Moriya S, Hosono M, Shima H, Miyagi T.
    PLoS One; 2015 Jul 15; 10(3):e0120578. PubMed ID: 25803810
    [Abstract] [Full Text] [Related]

  • 13. NEU3 sialidase strictly modulates GM3 levels in skeletal myoblasts C2C12 thus favoring their differentiation and protecting them from apoptosis.
    Anastasia L, Papini N, Colazzo F, Palazzolo G, Tringali C, Dileo L, Piccoli M, Conforti E, Sitzia C, Monti E, Sampaolesi M, Tettamanti G, Venerando B.
    J Biol Chem; 2008 Dec 26; 283(52):36265-71. PubMed ID: 18945680
    [Abstract] [Full Text] [Related]

  • 14. Plasma membrane-associated sialidase (NEU3) promotes formation of colonic aberrant crypt foci in azoxymethane-treated transgenic mice.
    Shiozaki K, Yamaguchi K, Sato I, Miyagi T.
    Cancer Sci; 2009 Apr 26; 100(4):588-94. PubMed ID: 19215228
    [Abstract] [Full Text] [Related]

  • 15. GM3 and cancer.
    Hakomori SI, Handa K.
    Glycoconj J; 2015 Feb 26; 32(1-2):1-8. PubMed ID: 25613425
    [Abstract] [Full Text] [Related]

  • 16. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
    Park SY, Yoon SJ, Freire-de-Lima L, Kim JH, Hakomori SI.
    Carbohydr Res; 2009 Aug 17; 344(12):1479-86. PubMed ID: 19559406
    [Abstract] [Full Text] [Related]

  • 17. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression.
    Kim DI, Lee SJ, Lee SB, Park K, Kim WJ, Moon SK.
    Carcinogenesis; 2008 Sep 17; 29(9):1701-9. PubMed ID: 18296682
    [Abstract] [Full Text] [Related]

  • 18. Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431.
    Meuillet EJ, Mania-Farnell B, George D, Inokuchi JI, Bremer EG.
    Exp Cell Res; 2000 Apr 10; 256(1):74-82. PubMed ID: 10739654
    [Abstract] [Full Text] [Related]

  • 19. Effects of gangliosides on the differentiation of human mesenchymal stem cells into osteoblasts by modulating epidermal growth factor receptors.
    Kim SM, Jung JU, Ryu JS, Jin JW, Yang HJ, Ko K, You HK, Jung KY, Choo YK.
    Biochem Biophys Res Commun; 2008 Jul 11; 371(4):866-71. PubMed ID: 18471991
    [Abstract] [Full Text] [Related]

  • 20. Role of sialidase Neu3 and ganglioside GM3 in cardiac fibroblasts activation.
    Ghiroldi A, Piccoli M, Creo P, Cirillo F, Rota P, D'Imperio S, Ciconte G, Monasky MM, Micaglio E, Garatti A, Aureli M, Carsana EV, Menicanti L, Pappone C, Anastasia L.
    Biochem J; 2020 Sep 18; 477(17):3401-3415. PubMed ID: 32869836
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.